On the public citation graph
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
0 signed · 118 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ajh.23108openalex-snapshot
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity
inferredcites →https://doi.org/10.1002/ajh.23812openalex-snapshot
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial
inferredcites →https://doi.org/10.1002/cncr.10851openalex-snapshot
The continuing increase in the incidence of primary central nervous system non‐Hodgkin lymphoma
inferredcites →https://doi.org/10.1002/cncr.21481openalex-snapshot
Trends in survival from primary central nervous system lymphoma, 1975–1999
inferredcites →https://doi.org/10.1002/cncr.22907openalex-snapshot
Patterns of treatment in older adults with primary central nervous system lymphoma
inferredcites →https://doi.org/10.1007/s12185-013-1403-zopenalex-snapshot
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation
inferredcites →https://doi.org/10.1007/s12185-014-1608-9openalex-snapshot
Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma
inferredcites →https://doi.org/10.1016/0895-4356(94)90129-5openalex-snapshot
Validation of a combined comorbidity index
inferredcites →https://doi.org/10.1016/j.bbmt.2008.05.002openalex-snapshot
Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma
inferredcites →https://doi.org/10.1016/j.bbmt.2014.01.025openalex-snapshot
High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Elderly Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: A Nationwide Retrospective Study
inferredcites →https://doi.org/10.1016/j.ijrobp.2006.03.061openalex-snapshot
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51
inferredcites →https://doi.org/10.1016/j.surneu.2006.05.055openalex-snapshot
Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan
inferredcites →https://doi.org/10.1016/s1470-2045(12)70259-0openalex-snapshot
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review
inferredcites →https://doi.org/10.1016/s2352-3026(15)00074-5openalex-snapshot
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial
inferredcites →https://doi.org/10.1016/s2352-3026(16)00036-3openalex-snapshot
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
inferredcites →https://doi.org/10.1016/s2352-3026(16)30050-3openalex-snapshot
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
inferredcites →https://doi.org/10.1038/bmt.2010.289openalex-snapshot
Outcomes of auto-SCT for lymphoma in subjects aged 70 years and over
inferredcites →https://doi.org/10.1038/bmt.2010.71openalex-snapshot
Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience
inferredcites →https://doi.org/10.1038/bmt.2014.255openalex-snapshot
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years
inferredcites →https://doi.org/10.1038/sj.bmt.1705452openalex-snapshot
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group
inferredcites →https://doi.org/10.1093/annonc/mdi075openalex-snapshot
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
inferredcites →https://doi.org/10.1093/annonc/mdl458openalex-snapshot
Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hämato-Onkologie OSHO-53 phase II study
inferredcites →https://doi.org/10.1093/annonc/mdp529openalex-snapshot
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d’Etude des Lymphomes de l’Adulte (GELA)
inferredcites →https://doi.org/10.1093/annonc/mds059openalex-snapshot
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study
inferredcites →https://doi.org/10.1093/annonc/mdv002openalex-snapshot
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study
inferredcites →https://doi.org/10.1093/annonc/mdv018openalex-snapshot
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary
inferredcites →https://doi.org/10.1093/annonc/mdv076openalex-snapshot
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis
inferredcites →https://doi.org/10.1111/j.1600-0609.2005.00508.xopenalex-snapshot
First‐line autologous stem cell transplantation in primary CNS lymphoma
inferredcites →https://doi.org/10.1159/000458147openalex-snapshot
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
inferredcites →https://doi.org/10.1182/blood-2014-10-604561openalex-snapshot
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
inferredcites →https://doi.org/10.1182/blood-2014-12-615187openalex-snapshot
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
inferredcites →https://doi.org/10.1200/jco.2000.18.17.3144openalex-snapshot
Treatment for Primary CNS Lymphoma: The Next Step
inferredcites →https://doi.org/10.1200/jco.2001.19.3.742openalex-snapshot
Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma
inferredcites →https://doi.org/10.1200/jco.2003.05.024openalex-snapshot
Intensive Methotrexate and Cytarabine Followed by High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Newly Diagnosed Primary CNS Lymphoma: An Intent-to-Treat Analysis
inferredcites →https://doi.org/10.1200/jco.2003.11.036openalex-snapshot
Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
inferredcites →https://doi.org/10.1200/jco.2006.06.2117openalex-snapshot
High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma
inferredcites →https://doi.org/10.1200/jco.2007.13.5533openalex-snapshot
Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire
inferredcites →https://doi.org/10.1200/jco.2010.28.1618openalex-snapshot
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
inferredcites →https://doi.org/10.1200/jco.2011.34.7625openalex-snapshot
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
inferredcites →https://doi.org/10.1212/wnl.0b013e318297eebaopenalex-snapshot
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma
inferredcites →https://doi.org/10.1634/theoncologist.2008-0236openalex-snapshot
Primary CNS Lymphoma in Immunocompetent Patients
inferredcites →https://doi.org/10.3109/10428194.2011.633250openalex-snapshot
Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience
inferredcites →https://doi.org/10.3109/10428194.2014.916800openalex-snapshot
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
inferredcites →https://doi.org/10.3324/haematol.10552openalex-snapshot
Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61 70 years: results of the prospective EORTC GIMEMA AML 13 study
inferredcites →https://doi.org/10.3324/haematol.11771openalex-snapshot
High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system
inferredcites →https://doi.org/10.3324/haematol.13273openalex-snapshot
Autologous stem cell transplantation in elderly patients (>=60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry
inferredcites →https://doi.org/10.3324/haematol.2011.060434openalex-snapshot
Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases
inferredcites →https://doi.org/10.3324/haematol.2012.076075openalex-snapshot
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
inferredcites →https://doi.org/10.3324/haematol.2014.108472openalex-snapshot
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4590911openalex-extracted
High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit PCNSL Patients – The Multicenter MARTA Study
inferred← citeshttps://doi.org/10.1002/ajh.24823openalex-snapshot
Thiotepa‐based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched‐pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
inferred← citeshttps://doi.org/10.1002/cam4.1581openalex-snapshot
The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1002/hem3.89openalex-snapshot
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up
inferred← citeshttps://doi.org/10.1002/jcp.29790openalex-snapshot
Advances and challenges in the treatment of primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1007/s00277-023-05140-6openalex-snapshot
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
inferred← citeshttps://doi.org/10.1007/s00277-025-06405-yopenalex-snapshot
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study
inferred← citeshttps://doi.org/10.1007/s00277-026-07216-5openalex-snapshot
Primary central nervous system lymphoma in the molecular era: genomic drivers, liquid biopsy, and targeted therapeutic strategies
inferred← citeshttps://doi.org/10.1007/s00701-022-05170-5openalex-snapshot
Diagnosis, treatment, and outcome of primary CNS lymphoma—a single-center experience
inferred← citeshttps://doi.org/10.1007/s11060-022-04064-xopenalex-snapshot
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost–benefit analysis
inferred← citeshttps://doi.org/10.1007/s11912-018-0666-1openalex-snapshot
Updates on Primary Central Nervous System Lymphoma
inferred← citeshttps://doi.org/10.1007/s11940-019-0578-xopenalex-snapshot
Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients
inferred← citeshttps://doi.org/10.1016/j.annonc.2023.11.010openalex-snapshot
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
inferred← citeshttps://doi.org/10.1016/j.bbmt.2019.01.020openalex-snapshot
High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry
inferred← citeshttps://doi.org/10.1016/j.bbmt.2019.04.004openalex-snapshot
Outcomes of Consecutively Diagnosed Primary Central Nervous System Lymphoma Patients Using the Alberta Lymphoma Clinical Practice Guideline Incorporating Thiotepa-Busulfan Conditioning for Transplantation-Eligible Patients
inferred← citeshttps://doi.org/10.1016/j.beha.2018.07.006openalex-snapshot
Improving outcomes in primary CNS lymphoma
inferred← citeshttps://doi.org/10.1016/j.clml.2018.11.018openalex-snapshot
Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1016/j.clml.2019.05.012openalex-snapshot
Temozolomide as a Single Agent Maintenance Therapy in Elderly Patients With Primary CNS Lymphoma
inferred← citeshttps://doi.org/10.1016/j.clml.2026.04.008openalex-snapshot
SOHO State of the Art Updates and Next Questions | Management of Primary Central Nervous System Lymphoma
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2023.104042openalex-snapshot
Challenges in the management of primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1016/j.esmoop.2021.100213openalex-snapshot
How we treat primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1016/j.hoc.2021.09.004openalex-snapshot
Primary Central Nervous System Lymphomas
inferred← citeshttps://doi.org/10.1016/j.jtct.2023.09.028openalex-snapshot
Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
inferred← citeshttps://doi.org/10.1016/j.jtct.2024.10.003openalex-snapshot
Sequential Conditioning With FLAMSA Does Not Improve Outcomes of Allogeneic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia Patients
inferred← citeshttps://doi.org/10.1016/j.lpm.2018.04.016openalex-snapshot
Management of primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1016/s2152-2650(25)00323-4openalex-snapshot
EXABS-137-LYM: Management of Primary CNS Lymphoma: Young and Old
inferred← citeshttps://doi.org/10.1016/s2352-3026(23)00371-xopenalex-snapshot
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial
inferred← citeshttps://doi.org/10.1038/s41409-022-01648-zopenalex-snapshot
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network
inferred← citeshttps://doi.org/10.1038/s41409-023-01928-2openalex-snapshot
Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1055/a-0601-0992openalex-snapshot
Aktuelle Therapiestandards primärer ZNS-Lymphome
inferred← citeshttps://doi.org/10.1080/0284186x.2019.1599137openalex-snapshot
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study
inferred← citeshttps://doi.org/10.1080/14737140.2019.1677157openalex-snapshot
Have treatment protocols for primary CNS lymphoma advanced in the past 10 years?
inferred← citeshttps://doi.org/10.1080/17474086.2022.2018297openalex-snapshot
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1093/neuonc/noac196openalex-snapshot
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
inferred← citeshttps://doi.org/10.1097/cm9.0000000000000844openalex-snapshot
Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment
inferred← citeshttps://doi.org/10.1097/wco.0000000000000492openalex-snapshot
Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?
inferred← citeshttps://doi.org/10.1097/wco.0000000000001115openalex-snapshot
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies
inferred← citeshttps://doi.org/10.1111/ajco.13780openalex-snapshot
Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study
inferred← citeshttps://doi.org/10.1111/bjh.15661openalex-snapshot
Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma
inferred← citeshttps://doi.org/10.1111/bjh.17799openalex-snapshot
Advances in treatment of elderly primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1159/000495284openalex-snapshot
Primary CNS Lymphoma in the Elderly: The Challenge
inferred← citeshttps://doi.org/10.1159/000511208openalex-snapshot
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?
inferred← citeshttps://doi.org/10.1177/1756286418793562openalex-snapshot
Primary central nervous system lymphoma
inferred← citeshttps://doi.org/10.1177/1756286420951087openalex-snapshot
HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series
inferred← citeshttps://doi.org/10.1182/asheducation-2017.1.565openalex-snapshot
Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents
inferred← citeshttps://doi.org/10.1182/bloodadvances.2020002064openalex-snapshot
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study
inferred← citeshttps://doi.org/10.1186/s12885-019-5473-zopenalex-snapshot
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients
inferred← citeshttps://doi.org/10.1186/s12885-023-11193-7openalex-snapshot
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial
inferred← citeshttps://doi.org/10.1200/edbk_242547openalex-snapshot
Evolving Treatments for Primary Central Nervous System Lymphoma
inferred← citeshttps://doi.org/10.1212/wnl.0000000000008900openalex-snapshot
Management and outcome of primary CNS lymphoma in the modern era
inferred← citeshttps://doi.org/10.1634/theoncologist.2017-0499openalex-snapshot
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis
inferred← citeshttps://doi.org/10.17650/1818-8346-2021-16-2-10-20openalex-snapshot
Treatment of primary central nervous system lymphomas
inferred← citeshttps://doi.org/10.21037/aol-21-20openalex-snapshot
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
inferred← citeshttps://doi.org/10.21037/tcr-22-2341openalex-snapshot
Recent advances and challenges in primary central nervous system lymphoma: a narrative review
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4403718/v1openalex-snapshot
The notable outcomes of modified thiotepa-based conditioning followed by autologous stem cell transplantation in primary central nervous system lymphomas: A real-life pilot study
inferred← citeshttps://doi.org/10.2147/ott.s192379openalex-snapshot
Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies
inferred← citeshttps://doi.org/10.3324/haematol.2017.185843openalex-snapshot
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients
inferred← citeshttps://doi.org/10.3324/haematol.2021.278613openalex-snapshot
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
inferred← citeshttps://doi.org/10.3389/fonc.2021.649789openalex-snapshot
Relapsed Primary Central Nervous System Lymphoma: Current Advances
inferred← citeshttps://doi.org/10.3390/cancers13143479openalex-snapshot
Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
inferred← citeshttps://doi.org/10.3390/cancers13174268openalex-snapshot
Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping Review
inferred← citeshttps://doi.org/10.3390/cancers14092100openalex-snapshot
High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity
inferred← citeshttps://doi.org/10.3390/cancers15030669openalex-snapshot
Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma
inferred← citeshttps://doi.org/10.35754/0234-5730-2019-64-4-447-461openalex-snapshot
HIGH-DOSE CHEMOTHERAPY FOR PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM. INTERIM RESULTS OF THE CNS-2015 PROTOCOL
inferred← citeshttps://doi.org/10.3892/ijo.2021.5180openalex-snapshot
Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review)
inferred← citeshttps://doi.org/10.5603/rpor.a2023.0028openalex-snapshot
Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective
inferred← citeshttps://doi.org/10.58931/cht.2025.4274openalex-snapshot
Management of Newly Diagnosed Primary Central Nervous System Lymphoma
inferred← citeshttps://doi.org/10.6084/m9.figshare.23993235openalex-snapshot
Additional file 1 of Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.